Jincong Q Freeman

Sep 29, 2023 | healio.com | Jennifer Southall |Mindy Valcarcel |Jincong Q Freeman

Source/Disclosures Source: Freeman J, et al. Trends and racial/ethnic disparities in palliative care use among patients with de novo metastatic breast cancer – National Cancer Database, 2004-2020. Presented at: AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Sept. 29-Oct. 2, 2023; Orlando. Disclosures: Breast Cancer Research Foundation, NCI/NIH and Susan G. Komen Breast Cancer Foundation supported the study.

May 6, 2023 | nature.com | Jincong Q Freeman |Frederick Howard |Rita Nanda

AbstractOncotypeDX and MammaPrint assays have not been validated to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in early-stage breast cancer patients. We analyzed the 2010–2019 National Cancer Database and found that high OncotypeDX recurrence scores or high MammaPrint scores were associated with greater odds of pCR.